carbenoxolone
This page covers all carbenoxolone drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Corticosteroid 11-beta-dehydrogenase isozyme 1.
Targets
Corticosteroid 11-beta-dehydrogenase isozyme 1
Phase 2 pipeline (1)
- Biogastrone · Gastroenterology
Biogastrone works by inhibiting the enzyme that converts cortisol into a more potent form, reducing inflammation in the stomach and esophagus.
Patent intelligence
- carbenoxolone patent landscape — aggregated cliff calendar, attackable patents, originator estates